R-103

N/A

Report date: 2023/01/08 21:47:49

Base Information

Drug NameR-103
Drug Alias NameABS-103RR-ABS-103
ClassificationOther
Mechanisms of ActionGABA receptors agonists
TargetsGABA receptors
Therapy Area/IndicationsBipolar DisorderMigraine DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmerican Biogenetic Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmerican Biogenetic Sciences
Active IndicationsN/A
Inactive IndicationsBipolar DisorderMigraine DisordersEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A